BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Business

  Survey Says There is a Disconnect Between Good Intent and Action in D&I Initiatives

  Diversity and Inclusion (D&I) have been at the forefront of the national conversation during this momentous year, so BioSpace felt it imperative to reach out to employees in the life sciences industry on this subject in our wide-ranging Fall 2020 Diversity and Inclusion Survey.

  December 7, 2020

   · 

  7 min read

   · 

  Heather McKenzie
• 

  Policy

  Pharma Organizations Sue Trump Administration Over Final Ruling to Lower Drug Prices

  Pharmaceutical Research and Manufacturers of America (PhRMA), alongside other biotech industry trade organizations, filed a lawsuit Friday against the Trump administration’s new rules for lowering drug prices.

  December 7, 2020

   · 

  3 min read

   · 

  Brandon May
• 

  Business

  ASH 2020: CRISPR and Vertex’s Potential Cure for Sickle Cell Disease and More Glimmers of Hope

  The American Society of Hematology (ASH) Annual Meeting & Exposition began December 5, and there were numerous presentations, abstracts and posters. Here’s a look at some of the stories out of the first day.

  December 7, 2020

   · 

  4 min read

   · 

  Mark Terry
• 

  Drug Development

  Abionic’s cSOFA Score Could Help Hospitals Anticipate COVID-19 Complications

  Swiss medtech company Abionic SA announced that they have developed the first COVID-19 severity test, the cSOFA (Covid Sequential Organ Failure Assessment) score, to help doctors quickly and accurately triage cases that come into emergency rooms.

  December 7, 2020

   · 

  5 min read

   · 

  Heather McKenzie
• 

  Pharm Country

  Roivant Announces Protein Degradation Platform Using VantAI Against Difficult Drug Targets

  Roivant Sciences announced its targeted protein degradation platform, with its first pipeline candidate expected to enter the clinic in 2021.

  December 7, 2020

   · 

  3 min read

   · 

  Mark Terry
• 

  Drug Development

  Constellation Announces Promising Results for Investigational Myelofibrosis Therapy

  Constellation Pharmaceuticals announced on Sunday that it has received preliminary data from its Phase II MANIFEST and Phase III MANIFEST-2 clinical trials involving CPI-0610 for myelofibrosis.

  December 7, 2020

   · 

  3 min read

   · 

  Krystle Vermes
• 

  Business

  Biden Taps California Attorney General Becerra to Lead HHS

  Experts anticipated his nomination as Biden’s Attorney General instead.

  December 7, 2020

   · 

  2 min read

   · 

  Kate Goodwin
• 

  4 Ways to Know if You Should Get a Master’s Degree

  Have you thought about going back to school to earn a master’s degree? Do you wonder if studying for an advanced degree is worth your time, energy and money?

  December 7, 2020

   · 

  3 min read

   · 

  Porschia Parker-Griffin
• 

  Business

  Bayer Leaps into CAR T-Cell Therapy Scene with Atara Biotherapeutics Collaboration

  The collaboration with Atara will focus on developing an off-the-shelf T-cell immunotherapy for high mesothelin-expressing tumors.

  December 7, 2020

   · 

  2 min read

   · 

  Alex Keown
• 

  Policy

  FDA Slows ALX Oncology’s HNSCC Study with New Safety Study Requirement

  Due to the registration potential of the mid-stage studies, the U.S. Food and Drug Administration requested the company complete a standard safety study, which amounts to a partial clinical hold on the study.

  December 7, 2020

   · 

  3 min read

   · 

  Alex Keown